Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Feb 9, 2026
Sale
Shares
5
Price
$781.48
Total Value
$3.91K
Shares Held After
17,812
% of Holdings
0.0%
Feb 9, 2026
Sale
Shares
1
Price
$780.09
Total Value
$780.09
Shares Held After
17,817
% of Holdings
0.0%
Feb 9, 2026
Sale
Shares
5
Price
$779.41
Total Value
$3.90K
Shares Held After
17,818
% of Holdings
0.0%
Feb 9, 2026
Sale
Shares
12
Price
$778.53
Total Value
$9.34K
Shares Held After
17,823
% of Holdings
0.1%
Feb 9, 2026
Sale
Shares
57
Price
$777.56
Total Value
$44.32K
Shares Held After
17,835
% of Holdings
0.3%
Feb 9, 2026
Sale
Shares
10
Price
$776.59
Total Value
$7.77K
Shares Held After
17,892
% of Holdings
0.1%
Feb 9, 2026
Sale
Shares
1
Price
$775.63
Total Value
$775.63
Shares Held After
17,902
% of Holdings
0.0%
Feb 9, 2026
Sale
Shares
53
Price
$785.72
Total Value
$41.64K
Shares Held After
4,272
% of Holdings
1.2%
Feb 9, 2026
Sale
Shares
1
Price
$784.66
Total Value
$784.66
Shares Held After
4,325
% of Holdings
0.0%
Feb 9, 2026
Sale
Shares
144
Price
$783.23
Total Value
$112.79K
Shares Held After
4,326
% of Holdings
3.2%
Feb 9, 2026
Sale
Shares
37
Price
$782.67
Total Value
$28.96K
Shares Held After
4,470
% of Holdings
0.8%
Feb 9, 2026
Sale
Shares
26
Price
$781.37
Total Value
$20.32K
Shares Held After
4,507
% of Holdings
0.6%
Feb 9, 2026
Sale
Shares
75
Price
$780.06
Total Value
$58.50K
Shares Held After
4,533
% of Holdings
1.6%
Feb 9, 2026
Sale
Shares
205
Price
$779.56
Total Value
$159.81K
Shares Held After
4,608
% of Holdings
4.3%
Feb 9, 2026
Sale
Shares
563
Price
$778.35
Total Value
$438.21K
Shares Held After
4,813
% of Holdings
10.5%
Feb 9, 2026
Sale
Shares
391
Price
$777.51
Total Value
$304.01K
Shares Held After
5,376
% of Holdings
6.8%
Feb 9, 2026
Sale
Shares
521
Price
$776.43
Total Value
$404.52K
Shares Held After
5,767
% of Holdings
8.3%
Feb 9, 2026
Sale
Shares
20
Price
$775.95
Total Value
$15.52K
Shares Held After
6,288
% of Holdings
0.3%

ILLUMINA, INC. (ILMN)

Gottlieb Scott — Director
Feb 9, 2026
Purchase
Shares
200
Price
$117.81
Total Value
$23.56K
Shares Held After
12,723
% of Holdings
1.6%
Feb 9, 2026
Purchase
Shares
115,000
Price
$16.00
Total Value
$1.84M
Shares Held After
251,427
% of Holdings
45.7%
Feb 9, 2026
Purchase
Shares
20,000
Price
$16.00
Total Value
$320.00K
Shares Held After
25,450
% of Holdings
78.6%
Feb 9, 2026
Purchase
Shares
312,500
Price
$16.00
Total Value
$5.00M
Shares Held After
2,187,513
% of Holdings
14.3%

Entera Bio Ltd. (ENTX)

Ellis Sean — Director
Feb 9, 2026
Purchase
Shares
18,000
Price
$1.24
Total Value
$22.32K
Shares Held After
178,098
% of Holdings
10.1%

Entera Bio Ltd. (ENTX)

Rubin Steven D — Director
Feb 9, 2026
Purchase
Shares
10,000
Price
$1.20
Total Value
$12.00K
Shares Held After
10,000
% of Holdings
100.0%
Feb 9, 2026
Sale
Shares
889
Price
$2.39
Total Value
$2.13K
Shares Held After
79,133
% of Holdings
1.1%

Zentalis Pharmaceuticals, Inc. (ZNTL)

Bruns Ingmar — Chief Medical Officer
Feb 9, 2026
Sale
Shares
335
Price
$2.39
Total Value
$801.62
Shares Held After
33,332
% of Holdings
1.0%
Feb 9, 2026
Sale
Shares
3,379
Price
$2.39
Total Value
$8.09K
Shares Held After
153,400
% of Holdings
2.2%
Feb 9, 2026
Sale
Shares
12,840
Price
$3.78
Total Value
$48.57K
Shares Held After
962,097
% of Holdings
1.3%

RAPID MICRO BIOSYSTEMS, INC. (RPID)

WIRTJES SEAN M — CHIEF FINANCIAL OFFICER
Feb 9, 2026
Sale
Shares
6,027
Price
$3.78
Total Value
$22.80K
Shares Held After
483,928
% of Holdings
1.2%

RAPID MICRO BIOSYSTEMS, INC. (RPID)

Wilson John J. Addington — CHIEF OPERATING OFFICER
Feb 9, 2026
Sale
Shares
4,610
Price
$3.78
Total Value
$17.44K
Shares Held After
257,768
% of Holdings
1.8%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 9, 2026
Sale
Shares
7,875
Price
$474.65
Total Value
$3.74M
Shares Held After
0
% of Holdings
100.0%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 9, 2026
Sale
Shares
14,625
Price
$474.65
Total Value
$6.94M
Shares Held After
0
% of Holdings
100.0%

ACADIA PHARMACEUTICALS INC (ACAD)

Rhodes Jennifer J — EVP, CHIEF LEGAL OFFICER, SEC
Feb 9, 2026
Sale
Shares
6,950
Price
$23.38
Total Value
$162.49K
Shares Held After
7,609
% of Holdings
47.7%
Shares
165,000
Price
$16.00
Total Value
$2.64M
Shares Held After
3,310,619
% of Holdings
5.0%
Feb 9, 2026
Purchase
Shares
165,000
Price
$16.00
Total Value
$2.64M
Shares Held After
3,310,619
% of Holdings
5.0%
Feb 9, 2026
Sale
Shares
14,625
Price
$8.56
Total Value
$125.19K
Shares Held After
387,225
% of Holdings
3.6%

Biogen Inc. (BIIB)

Singhal Priya — Head of Development
Feb 9, 2026
Sale
Shares
2,660
Price
$199.83
Total Value
$531.55K
Shares Held After
8,043
% of Holdings
24.9%
Feb 9, 2026
Sale
Shares
88
Price
$275.53
Total Value
$24.25K
Shares Held After
2,869
% of Holdings
3.0%

RESMED INC (RMD)

Farrell Michael J. — Director
Feb 9, 2026
Sale
Shares
4,991
Price
$273.78
Total Value
$1.37M
Shares Held After
466,223
% of Holdings
1.1%
Feb 9, 2026
Sale
Shares
17,159
Price
$21.03
Total Value
$360.82K
Shares Held After
491,690
% of Holdings
3.4%

Syndax Pharmaceuticals, Inc. (SNDX)

Goldan Keith A. — Chief Financial Officer
Feb 9, 2026
Sale
Shares
3,410
Price
$21.03
Total Value
$71.71K
Shares Held After
140,429
% of Holdings
2.4%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Feb 9, 2026
Sale
Shares
14,261
Price
$16.66
Total Value
$237.62K
Shares Held After
42,749
% of Holdings
25.0%
Feb 9, 2026
Sale
Shares
100
Price
$198.00
Total Value
$19.80K
Shares Held After
2,900
% of Holdings
3.3%
Feb 9, 2026
Sale
Shares
375
Price
$198.00
Total Value
$74.25K
Shares Held After
22,852
% of Holdings
1.6%

Merck & Co., Inc. (MRK)

Zachary Jennifer — EVP, General Counsel
Feb 9, 2026
Sale
Shares
38,835
Price
$119.15
Total Value
$4.63M
Shares Held After
68,916
% of Holdings
36.0%

Merck & Co., Inc. (MRK)

Zachary Jennifer — EVP, General Counsel
Feb 9, 2026
Sale
Shares
56,792
Price
$119.15
Total Value
$6.77M
Shares Held After
68,916
% of Holdings
45.2%

Merck & Co., Inc. (MRK)

Zachary Jennifer — EVP, General Counsel
Feb 9, 2026
Sale
Shares
25,946
Price
$119.15
Total Value
$3.09M
Shares Held After
68,916
% of Holdings
27.4%

Merck & Co., Inc. (MRK)

Guindo Chirfi — Chief Marketing Officer
Feb 9, 2026
Sale
Shares
10,000
Price
$118.41
Total Value
$1.18M
Shares Held After
70,615
% of Holdings
12.4%
Feb 6, 2026
Purchase
Shares
194
Price
$9.86
Total Value
$1.91K
Shares Held After
156,957
% of Holdings
0.1%
Feb 6, 2026
Sale
Shares
7,866
Price
$2.43
Total Value
$19.11K
Shares Held After
80,022
% of Holdings
9.0%
Version: v26.3.33